Evidence map›Paper›PMID 35700473›Full record

ArticleRevista de la Facultad de Ciencias Medicas (Cordoba, Argentina)2022

[Characterization of the problem of the therapeutic use of Cannabis Oil in Córdoba, Argentina].

Pablo Gabriel Manzo, Sandra Martín, Sonia Uema, Germán Charles, Felipe Montero Bruni, Susana Núñez Montoya, María Eugenia Bertotto, Martín Eynard, Pedro Armando, Carolina Bustos Fierro

Abstract read
In one paragraph

Article in Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pablo Gabriel ManzoUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Centro de Química Aplicada (Cequimap). Córdoba, Argentina. . pgmanzo@gmail.com.
Sandra MartínUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Departamento de Química Orgánica. Córdoba, Argentina.. martins@fcq.unc.edu.ar.
Sonia UemaUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Centro de Información de Medicamentos (CIME). Córdoba, Argentina. . suema@fcq.unc.edu.ar.
Germán CharlesUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Centro de Química Aplicada (Cequimap). Córdoba, Argentina. . gcharles@fcq.unc.edu.ar.
Felipe Montero BruniUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Centro de Química Aplicada (Cequimap). Córdoba, Argentina. . felipe.m@live.cl.
Susana Núñez MontoyaUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Dpto. Ciencias Farmacéuticas y Centro de Información de Medicamentos (CIME). Córdoba, Argentina. . sununez@unc.edu.ar.
María Eugenia BertottoUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Centro de Información de Medicamentos (CIME) y Departamento de Farmacología. Córdoba, Argentina. . mebertotto@unc.edu.ar.
Martín EynardUniversidad Nacional de Córdoba, Facultad de Ciencias Médicas, Cátedra de Medicina Antropológica. Córdoba, Argentina. . eynardmartin@yahoo.com.ar.
Pedro ArmandoUniversidad Nacional de Córdoba, Facultad de Ciencias Químicas, Departamento de Farmacología. Córdoba, Argentina. . pdarmando@yahoo.es.
Carolina Bustos FierroUniversidad Nacional de Córdoba, Facultad de Ciencias Médicas, Hospital Nacional de Clínicas, Farmacia Central. Córdoba, Argentina. . carobustosfierro@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The therapeutic use of the “cannabis” oil is a social problem that puts legal, health, scientific and cultural aspects under stress. Difficulty in access generates an emptiness exploited by the illegal market, to which patients and relatives resort to improve their health and quality of life. These oils, with unknown chemical composition, are used without therapeutic follow-up. An interdisciplinary team from the Universidad Nacional de Córdoba (UNC) started the study of this problem with the aim of characterizing the socio-therapeutic use of “cannabis" oil in Córdoba and establishing a relationship with the real content of cannabinoids. Methodology: Observational-descriptive and cross-sectional study approved by the Comité Institucional de Ética de las Investigaciones en Salud, Hospital Nacional de Clínicas from UNC (CIEIS-HNC-UNC): interviews with patients/caregivers of legal age who used the “cannabis” oil (year 2019). Experimental study: analysis of oil samples obtained from interviewees to determine their cannabinoid content, specifically delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), by High Performance Liquid Chromatography analysis (HPLC). Results: thirty-seven interviews were conducted, and 48 samples were analysed. The 73% were adults and older adults. The 92% started using the oil without prescription or medical suggestion, mainly due to the lack of effectiveness of other therapies (54%) and in the search for therapeutic alternatives (33%). The 84% perceived it to be effective (moderate to highly effective), and 78% reported no adverse events. Main uses: refractory epilepsy 27% and arthritis/arthrosis 24%. Fifteen percent of the samples showed no quantifiable content of CBD and THC, and 67% had only THC. The quantifiable content of cannabinoids was very low. Conclusions: This work allowed carrying out a preliminary information-gathering on several aspects (social and therapeutic) about the use of “cannabis” oil in Córdoba, and to analyze the chemical quality of the oils consumed. An important finding was the discrepancy between the effectiveness perceived by users and the low cannabinoid content detected.

Indexed as

CannabisArgentinaDronabinolHumansRetrospective StudiesDronabinolcannabidiolcannabinoids (therapeutic use)dronabinol

Identifiers

PMID35700473
PMCPMC9426324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.